Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 706 (USA) (Dr. Rossi)
· consented 2013-05-14
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-06-03 (study day 21.0); relationship: POSSIBLE
severe
assessed
2026-08-18
Severe SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-06-18 (study day 36.0); relationship: PROBABLE; serious criteria: hospitalization
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.